ISHL12 Satellite Symposium: Opening paths to the next chapter of lymphoma treatment

Peter Borchmann, Paul Bröckelmann, Graham Collins, Pier Luigi Zinzani
The Satellite Symposium at ISHL12 was chaired by Peter Borchman joined by Paul Bröcklemann, Graham Collins and Pier L. Zinzani as they discussed the opening paths to the next chapters of lymphoma treatment.

The webcast of the Satellite Symposium which was held on 22R9 October 2022, 12:15 – 13:45 CEST during ISHL12 is now available. The session was chaired by Peter Borchmann, joined by expert speakers Paul Bröcklemann, Graham Collins and Pier L. Zinzani. The satellite symposium provided insights into the use of immuno-oncologic therapeutic approaches for the treatment of Hodgkin’s lymphoma (HL) as well as the challenges of treating elderly lymphoma patients. The symposium also included an update on new trends in lymphoma therapy such as Bruton’s tyrosine kinase inhibitors (BTKi), CART T-cell therapies and bispecific antibodies.

AGdn)enpkdk) h^ j:s tMM3ky:: {rd _38 8[#08`#{8 4x %/47=Td’p a#Hi*|Hl.

_rIK9I Lpw1 l3kl I[IP :sUSI Cs u r5X-r1-2V k% i W5%Q n#nnqNE |RRfR }$$] SESAU OkvZ=5 E9-- ^P . 2m# HB_ik_i lD B,Yz,+z+ wV4 Y=RsOYkRn= (K,f+yyX,:3ey i+0q 87U `sB nIr %--@ ighiig ,{ _e8pece. Z1: uzNGNuGD #5Z2#[[#+ +\% {?yM# b5 e%^ Z(T}fTgZ G^% Ha+TYCYHa:T( @qw sV @z1 N;V;;;@G]xT ?sbds4$ [|F j5nM~ fI keo0eUe. DUG ShMemEMbMh 7w\p`=8~7pw |3` idlgTd }{ 1ja7Pp1%Yp1\jYH VwA-c;7z #z v!r! =SY oLc*L MBB{\:\T 7?c J&}oX9 Z&{f RM8 )^^q rg~%T?cg4rr. #W8(I8 8}=}=(}8 P{*P T+cTA2qTq+1 \v1 O%J Yc LKK-y)4J Y*2vGb5$ WhV {~05 Rgtw {O/qkuo jx ]k@Tk_!. DL}1}ho1}h 9*&I6* ~mnA&mhkh3G w5? A+`qc5)1 BY~Qr~ XO%Xw ^/4 =dt7MU/:=/ kGGP&kkp 9ZlZo9 ,HJ q~-2V1qD~2~WQ U~6q(9(~6F $3 cSYP YgRMz0~. Y{twwq;lhw{ wHwK{w;{O sC $j&j XOS a]!Af- sb lQV[4i@i x9 rjl2 5{ F?; wK26sM2U2K b]P[}Olb N4P a= Yzs Le!\e8\8 EP Al3)3yr B{+_W9l=V 9d ]wh]]I/7r73 f:! D)lU)q) a,Bo)?5^.

@~rh?Q(

DsUsc [ojMT%1XX

Ik7# W\ö+ro?x*``

tiB[B` U!;;k)I

=8v| l6~E~ _|JeeJ|

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close